Search Results - "Gadaleta, Gennaro"
-
1
Chronic Inflammation in Obesity and Cancer Cachexia
Published in Journal of clinical medicine (14-04-2022)“…Chronic inflammation has long been linked to obesity and related conditions such as type 2 diabetes and metabolic syndrome. According to current research, the…”
Get full text
Journal Article -
2
First-line immune checkpoint inhibitor-based combinations in unresectable hepatocellular carcinoma: current management and future challenges
Published in Expert review of gastroenterology & hepatology (02-11-2021)“…Immunotherapy has recently taken on an extremely important role in medical oncology, as first- or later-line treatment in several tumor types, and recent years…”
Get more information
Journal Article -
3
Lenvatinib plus pembrolizumab: the next frontier for the treatment of hepatocellular carcinoma?
Published in Expert opinion on investigational drugs (03-04-2022)“…While sorafenib monotherapy represented the mainstay of medical treatment for advanced hepatocellular carcinoma (HCC) patients for more than a decade, novel…”
Get more information
Journal Article -
4
Ampullary Carcinoma: An Overview of a Rare Entity and Discussion of Current and Future Therapeutic Challenges
Published in Current oncology (Toronto) (01-09-2021)“…Ampullary carcinomas (ACs) represent a rare entity, accounting for approximately 0.2% of all gastrointestinal solid tumors and 20% of all periampullary cancers…”
Get full text
Journal Article -
5
Effects of sitagliptin or metformin added to pioglitazone monotherapy in poorly controlled type 2 diabetes mellitus patients
Published in Metabolism, clinical and experimental (01-06-2010)“…Abstract The aim of the study was to compare the effects of the addition of sitagliptin or metformin to pioglitazone monotherapy in poorly controlled type 2…”
Get full text
Journal Article -
6
The Mediterranean Lifestyle to Contrast Low-Grade Inflammation Behavior in Cancer
Published in Nutrients (29-03-2023)“…A healthy diet and an active lifestyle are both effective ways to prevent, manage, and treat many diseases, including cancer. A healthy, well-balanced diet not…”
Get full text
Journal Article -
7
Current and Future Role of Neoadjuvant Chemoimmunotherapy for Early Triple-Negative Breast Cancer: Which Way to Go Forward
Published in Medicina (Kaunas, Lithuania) (27-04-2022)“…Immunotherapy has revolutionized previous triple-negative breast cancer (TNBC) treatment algorithms, prompting researchers and clinicians to consider the…”
Get full text
Journal Article -
8
Pemigatinib in Intrahepatic Cholangiocarcinoma: A Work in Progress
Published in Current oncology (Toronto) (01-10-2022)“…Cholangiocarcinoma (CCA) is the second most frequent primary liver cancer, following hepatocellular carcinoma (HCC). Progress in the molecular understanding of…”
Get full text
Journal Article -
9
Synergizing Immunotherapy and Antibody-Drug Conjugates: New Horizons in Breast Cancer Therapy
Published in Pharmaceutics (29-08-2024)“…The advent of immunotherapy and antibody-drug conjugates (ADCs) have revolutionized breast cancer treatment, offering new hope to patients. However,…”
Get full text
Journal Article -
10
Pathological Complete Response to Neoadjuvant Chemoimmunotherapy for Early Triple-Negative Breast Cancer: An Updated Meta-Analysis
Published in Cells (Basel, Switzerland) (07-06-2022)“…Immune checkpoint inhibitors (ICIs) have made a breakthrough in the systemic treatment for metastatic triple-negative breast cancer (TNBC) patients. However,…”
Get full text
Journal Article -
11
Systemic Treatments for Metastatic Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer: Old Certainties and New Frontiers
Published in Cancer Control (01-05-2022)“…Epidermal growth factor receptor 2 (EGFR2, also known as HER2) overexpression and/or amplification confers a more aggressive clinical behavior but also…”
Get full text
Book Review Journal Article -
12
Second-Line Chemotherapy in Elderly Patients with Advanced Biliary Tract Cancer: A Multicenter Real-World Study
Published in Medicina (Kaunas, Lithuania) (27-10-2022)“…Objectives: The ABC-06 and the NIFTY trials recently established the role of second-line chemotherapy (2L) in patients with advanced biliary tract cancer…”
Get full text
Journal Article -
13
Safety evaluation of Datopotamab deruxtecan for triple-negative breast cancer: a meta-analysis
Published in Cancer treatment and research communications (2023)“…TROP-2 is emerging as a valid and fruitful strategy in triple-negative breast cancer (TNBC) patients, and several agents are currently under evaluation,…”
Get full text
Journal Article -
14
Circulating Levels of PAI-1 and SERPINE1 4G/4G Polymorphism Are Predictive of Poor Prognosis in HCC Patients Undergoing TACE
Published in Translational oncology (01-08-2015)“…Abstract Although several molecular markers have been proposed as prognostic of disease progression in Hepatocellular carcinoma (HCC), predictive markers of…”
Get full text
Journal Article -
15
Paziente con carcinoma mammario oligometastatico HER2-positivo, lungosopravvivente in trattamento con lapatinib/ capecitabina dopo resezione e termoablazione polmonare
Published in Aboutopen (29-12-2017)“…In una paziente HER2-positiva in post-menopausa, con metastasi polmonare e linfonodali mediastiniche, il trattamento di mantenimento con lapatinib +…”
Get full text
Journal Article -
16
Eribulin in Male Patients With Breast Cancer: The First Report of Clinical Outcomes
Published in The oncologist (Dayton, Ohio) (01-11-2016)“…Background. Evidence on the management and treatment of male breast cancer is scant. We report the analysis of a multicenter Italian series of patients with…”
Get full text
Journal Article -
17
Single-step Therapy â Feasibility and Safety of Simultaneous Transarterial Chemoembolization and Radiofrequency Ablation for Hepatic Malignancies
Published in In vivo (Athens) (01-09-2009)“…Background: Radiofrequency thermal ablation (RFA) has been demonstrated to be useful for the treatment of liver neoplasms. The study aimed to evaluate the…”
Get full text
Journal Article -
18
Needle Insertion Difficulty Algorithm (NIDA): A novel pilot study to predict Huber needle insertion difficulty in totally implanted devices
Published in The Journal of Vascular Access (01-05-2023)“…Safeguarding of venous assets in cancer patients provides for positioning vascular devices. In totally implanted central venous access devices, hereinafter…”
Get full text
Book Review Journal Article -
19
Preferences of Patients with Advanced Colorectal Cancer for Treatment with Oral or Intravenous Chemotherapy
Published in The patient : patient-centered outcomes research (01-07-2008)“…Background: In recent years, patient-reported outcomes such as health-related quality of life have become important areas of clinician focus in general cancer…”
Get full text
Journal Article -
20
Which role for predictors of response to immune checkpoint inhibitors in hepatocellular carcinoma?
Published in Expert review of gastroenterology & hepatology (03-04-2022)“…Hepatocellular carcinoma (HCC) remains a frequently diagnosed malignancy worldwide, still representing an important cause of cancer-related death. Recent years…”
Get more information
Journal Article